D Braguer

Safety and efficacy of temozolomide in patients with recurrent anaplastic oligodendrogliomas after standard radiotherapy and chemotherapy.

O. Chinot, D. Figarella-Branger, D. Braguer, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pretreatment by tubulin agents decreases C-MYC induction in human colon carcinoma cell line HT29-D4.

D. Braguer, C. Briand, D Braguer, 1997, Biochemical and biophysical research communications.

Microtubules in apoptosis induction: are they necessary?

M. Carré, D. Braguer, D Braguer, 2007, Current cancer drug targets.